학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 549건 | 목록 1~20
Academic Journal
Moreno-Castaño AB; Hemostasis and Erythropathology Laboratory, Hematopathology, Pathology Department, Centre Diagnòstic Biomèdic (CDB), Clínic Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.; Fernández S; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.; Medical Intensive Care Unit, Clínic Barcelona, Barcelona, Spain.; Brillembourg H; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Iraola G; Medical Intensive Care Unit, Clínic Barcelona, Barcelona, Spain.; Moreno DF; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Ventosa-Capell H; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.; Medical Intensive Care Unit, Clínic Barcelona, Barcelona, Spain.; Martinez-Sanchez J; Hemostasis and Erythropathology Laboratory, Hematopathology, Pathology Department, Centre Diagnòstic Biomèdic (CDB), Clínic Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; De Moner B; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.; Josep Carreras Leukaemia Research Institute (Campus Clinic), Barcelona, Spain.; Hemostasis and Erythropathology Laboratory, Hematopathology, Pathology Department, Centre Diagnòstic Biomèdic (CDB), Clínic Barcelona, Barcelona, Spain.; Molina P; Hemostasis and Erythropathology Laboratory, Hematopathology, Pathology Department, Centre Diagnòstic Biomèdic (CDB), Clínic Barcelona, Barcelona, Spain.; Ramos A; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Palomo M; Hematology External Quality Assessment Laboratory, Centre de Diagnòstic Biomèdic, Clínic Barcelona, Barcelona, Spain.; Gómez-Ramírez P; Hemostasis and Erythropathology Laboratory, Hematopathology, Pathology Department, Centre Diagnòstic Biomèdic (CDB), Clínic Barcelona, Barcelona, Spain.; Ortiz-Maldonado V; Hematology Department, Institut del Càncer i Malalties de la Sang (ICAMS), IDIBAPS, Hospital Clínic de Barcelona, Barcelona, Spain.; Martínez-Cibrián N; Hematology Department, Institut del Càncer i Malalties de la Sang (ICAMS), IDIBAPS, Hospital Clínic de Barcelona, Barcelona, Spain.; Delgado J; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.; Hematology Department, Institut del Càncer i Malalties de la Sang (ICAMS), IDIBAPS, Hospital Clínic de Barcelona, Barcelona, Spain.; Oliver-Caldés A; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Hematology Department, Institut del Càncer i Malalties de la Sang (ICAMS), IDIBAPS, Hospital Clínic de Barcelona, Barcelona, Spain.; Fernández de Larrea C; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.; Hematology Department, Institut del Càncer i Malalties de la Sang (ICAMS), IDIBAPS, Hospital Clínic de Barcelona, Barcelona, Spain.; Salas MQ; Hematology Department, Institut del Càncer i Malalties de la Sang (ICAMS), IDIBAPS, Hospital Clínic de Barcelona, Barcelona, Spain.; Urbano Á; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.; Hematology Department, Institut del Càncer i Malalties de la Sang (ICAMS), IDIBAPS, Hospital Clínic de Barcelona, Barcelona, Spain.; Téllez A; Medical Intensive Care Unit, Clínic Barcelona, Barcelona, Spain.; Nicolás JM; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.; Medical Intensive Care Unit, Clínic Barcelona, Barcelona, Spain.; Juan M; Immunology Department, Centre de Diagnòstic Biomèdic, Clínic Barcelona, Barcelona, Spain.; González-Navarro A; Immunology Department, Centre de Diagnòstic Biomèdic, Clínic Barcelona, Barcelona, Spain.; Penack O; Charité Hospital, Berlin, Germany.; Escolar G; Hemostasis and Erythropathology Laboratory, Hematopathology, Pathology Department, Centre Diagnòstic Biomèdic (CDB), Clínic Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.; Carreras E; Josep Carreras Leukaemia Research Institute (Campus Clinic), Barcelona, Spain.; Fernández-Avilés F; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.; Hematology Department, Institut del Càncer i Malalties de la Sang (ICAMS), IDIBAPS, Hospital Clínic de Barcelona, Barcelona, Spain.; Castro P; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.; Medical Intensive Care Unit, Clínic Barcelona, Barcelona, Spain.; Diaz-Ricart M; Hemostasis and Erythropathology Laboratory, Hematopathology, Pathology Department, Centre Diagnòstic Biomèdic (CDB), Clínic Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Academic Journal
Fernández de Larrea C; Amyloidosis and Multiple Myeloma Unit, Department of Hematology, Hospital Clínic of Barcelona, Universitat de Barcelona, Villarroel 170, Barcelona, 08036, Spain.; Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.; Loscertales J; Hospital Universitario de La Princesa, Madrid, Spain.; Cabañas V; Hospital Universitario Virgen de la Arrixaca, Murcia, Spain.; Freiria C; Hospital General Universitario de Castellón, Castellón, Spain.; Blanchard MJ; Hospital Universitario Ramón y Cajal, Madrid, Spain.; Askari E; Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.; Lorenzo Pérez M; Hospital Álvaro Cunqueiro, Vigo, Spain.; Abril L; Hospital Universitari Germans Trias I Pujol, ICO Badalona, Badalona, Spain.; López Pardo J; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Pinzón S; Hospital del Mar, Barcelona, Spain.; Díaz Gálvez J; Hospital Universitario de Burgos, Burgos, Spain.; Amer N; Hospital Son Llàtzer (IdISBa), Palma de Mallorca, Spain.; Ramírez Páyer Á; Hospital Universitario Central de Asturias, Oviedo, Spain.; García Sánchez R; Hospital Universitario Virgen de la Victoria, Málaga, Spain.; Alcalá MM; Hospital Regional Universitario de Málaga, Málaga, Spain.; Capote FJ; Hospital Universitario Puerta del Mar, Cádiz, Spain.; Moreno D; Hospital Clínic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.; Bolumburu C; Janssen-Cilag, S.A., Johnson & Johnson, Madrid, Spain.; Rubio-Azpeitia E; Janssen-Cilag, S.A., Johnson & Johnson, Madrid, Spain.; García Sanz R; Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Publisher: Sage Country of Publication: England NLM ID: 101549589 Publication Model: eCollection Cited Medium: Print ISSN: 2040-6207 (Print) Linking ISSN: 20406207 NLM ISO Abbreviation: Ther Adv Hematol Subsets: PubMed not MEDLINE
Academic Journal
de la Cámara MÁ; Department of Educational Sciences, University of Alcalá (UAH), Alcalá de Henares, 28801, Spain.; Centro Nacional de Epidemiología, Instituto de Salud Carlos III (ISCIII), Monforte de Lemos 5, Madrid, 28029, Spain.; Fernández de Larrea-Baz N; Centro Nacional de Epidemiología, Instituto de Salud Carlos III (ISCIII), Monforte de Lemos 5, Madrid, 28029, Spain. nfernandez@isciii.es.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, 28029, Spain. nfernandez@isciii.es.; Pastor-Barriuso R; Centro Nacional de Epidemiología, Instituto de Salud Carlos III (ISCIII), Monforte de Lemos 5, Madrid, 28029, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, 28029, Spain.; Fernández-Navarro P; Centro Nacional de Epidemiología, Instituto de Salud Carlos III (ISCIII), Monforte de Lemos 5, Madrid, 28029, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, 28029, Spain.; Pollán M; Centro Nacional de Epidemiología, Instituto de Salud Carlos III (ISCIII), Monforte de Lemos 5, Madrid, 28029, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, 28029, Spain.; Pérez-Gómez B; Centro Nacional de Epidemiología, Instituto de Salud Carlos III (ISCIII), Monforte de Lemos 5, Madrid, 28029, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, 28029, Spain.
Publisher: BioMed Central Country of Publication: England NLM ID: 100968562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-2458 (Electronic) Linking ISSN: 14712458 NLM ISO Abbreviation: BMC Public Health Subsets: MEDLINE
Academic Journal
Munárriz D; Hospital Clínic de Barcelona, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.; Rodríguez-Lobato LG; Hospital Clínic de Barcelona, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.; López-Corral L; University Hospital of Salamanca, Biomedical Research Institute of Salamanca Instituto de Investigación Biomédica de Salamanca, Cancer Research Center Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC) , Salamanca, Spain.; Arnaldos-Pérez C; Hospital Clínic de Barcelona, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.; Cabañas V; Virgen de la Arrixaca University Clinical Hospital, Instituto Murciano de Investigación Biosanitaria-Arrixaca, University of Murcia, Murcia, Spain.; López-Muñoz N; University Hospital 12 de Octubre, Complutense University, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Oliver-Caldés A; Hospital Clínic de Barcelona, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.; Ponce JC; University Clinic of Navarra, Center for Applied Medical Research (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Centro de Investigación Biomédica en Red (CIBERONC) CB16/12/00369, Pamplona, Spain.; Reguera JL; Virgen del Rocío University Hospital, Institute of Biomedicine of Seville (IBIS/CSIC/Centro de Investigación Biomédica en Red (CIBERONC)), University of Seville, Seville, Spain.; Martín AÁ; University Hospital of Salamanca, Biomedical Research Institute of Salamanca Instituto de Investigación Biomédica de Salamanca, Cancer Research Center Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC) , Salamanca, Spain.; Martínez-Cibrián N; Hospital Clínic de Barcelona, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.; Tovar N; Hospital Clínic de Barcelona, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.; Delgado J; Hospital Clínic de Barcelona, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.; Guillen E; Hospital Clínic de Barcelona, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.; Varea S; Hospital Clínic de Barcelona, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.; Rodríguez-Otero P; University Clinic of Navarra, Center for Applied Medical Research (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Centro de Investigación Biomédica en Red (CIBERONC) CB16/12/00369, Pamplona, Spain.; Urbano-Ispizua Á; Hospital Clínic de Barcelona, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.; Moraleda JM; Virgen de la Arrixaca University Clinical Hospital, Instituto Murciano de Investigación Biosanitaria-Arrixaca, University of Murcia, Murcia, Spain.; Martínez-López J; University Hospital 12 de Octubre, Complutense University, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Mateos MV; University Hospital of Salamanca, Biomedical Research Institute of Salamanca Instituto de Investigación Biomédica de Salamanca, Cancer Research Center Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC) , Salamanca, Spain.; De la Calle VG; University Hospital of Salamanca, Biomedical Research Institute of Salamanca Instituto de Investigación Biomédica de Salamanca, Cancer Research Center Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC) , Salamanca, Spain.; González-Navarro EA; Hospital Clínic de Barcelona, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.; Fernández de Larrea C; Hospital Clínic de Barcelona, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Academic Journal
Oliver-Caldes A; Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain.; Mañe Pujol J; Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain.; Battram AM; Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain.; Perez-Amill L; Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain.; Bachiller M; Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain.; Calderon H; Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain.; Castella M; Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain.; Carpio J; Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain.; Salsench SV; Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain.; Tovar N; Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain.; Cardus O; Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain.; Urbano-Ispizua A; Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain.; Moreno DF; Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain.; Rodríguez-Lobato LG; Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain.; Lozano E; Universitat de Barcelona, Barcelona, Spain.; Rosiñol L; Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain.; Juan M; Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain.; Martín-Antonio B; Instituto de Salud Carlos III, Madrid, Spain.; Fernández de Larrea C; Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain.
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
Academic Journal
de la Cámara MÁ; National Centre for Epidemiology, Instituto de Salud Carlos III, Monforte de Lemos, 5, Madrid, Spain, 34 918222862.; Department of Educational Sciences, University of Alcalá, Alcalá de Henares, Spain.; Fernández de Larrea-Baz N; National Centre for Epidemiology, Instituto de Salud Carlos III, Monforte de Lemos, 5, Madrid, Spain, 34 918222862.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Pastor-Barriuso R; National Centre for Epidemiology, Instituto de Salud Carlos III, Monforte de Lemos, 5, Madrid, Spain, 34 918222862.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Larrauri A; National Centre for Epidemiology, Instituto de Salud Carlos III, Monforte de Lemos, 5, Madrid, Spain, 34 918222862.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Fernández-Navarro P; National Centre for Epidemiology, Instituto de Salud Carlos III, Monforte de Lemos, 5, Madrid, Spain, 34 918222862.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Pollán M; National Centre for Epidemiology, Instituto de Salud Carlos III, Monforte de Lemos, 5, Madrid, Spain, 34 918222862.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Pérez-Gómez B; National Centre for Epidemiology, Instituto de Salud Carlos III, Monforte de Lemos, 5, Madrid, Spain, 34 918222862.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Publisher: JMIR Publications Country of Publication: Canada NLM ID: 101669345 Publication Model: Electronic Cited Medium: Internet ISSN: 2369-2960 (Electronic) Linking ISSN: 23692960 NLM ISO Abbreviation: JMIR Public Health Surveill Subsets: MEDLINE
Academic Journal
Moreno DF; Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.; Nadeu F; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Brasó-Maristany F; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.; Institute of Cancer and Blood Diseases, Barcelona, Spain.; Reveal Genomics, Barcelona, Spain.; Vaqué S; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.; Paz S; Hematopathology Unit, Department of Pathology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.; Mañé J; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.; Cardús O; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.; Medina E; Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.; Lozano E; Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.; Rodríguez-Lobato LG; Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.; de Daniel A; Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.; Tovar N; Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.; Cibeira MT; Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.; Bladé J; Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.; Rosiñol L; Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.; Prat A; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.; Institute of Cancer and Blood Diseases, Barcelona, Spain.; Reveal Genomics, Barcelona, Spain.; Breast Cancer Unit, Institute of Oncology (IOB)-QuirónSalud, Barcelona, Spain.; Colomer D; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Hematopathology Unit, Department of Pathology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.; Fernández de Larrea C; Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Academic Journal
Zabaleta A; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC number CB16/12/00369, Pamplona, Spain, Pamplona, Spain.; Tamariz-Amador LE; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CCUN, CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Pamplona, Spain.; Kostopoulos IV; Department of Biology, National and Kapodistrian University of Athens, Athens, Greece, Greece.; Sklavenitis Pistofidis R; 3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; 4Harvard Medical School, Boston, MA; 5Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, United States.; Smits F; 6Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands; 7Cancer Biology and Immunology, Cancer Center Amsterdam, Amsterdam, Netherlands; 8Department of Hematology, HagaZiekenhuis, The Hague, Netherlands, Netherlands.; Rodriguez-Otero P; Cancer Center Clínica Universidad de Navarra, Pamplona, Spain.; Roncal C; CIMA, Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra, IdisNA, Pamplona, Spain.; Aranha MP; 3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; 4Harvard Medical School, Boston, MA; 5Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, United States.; Žihala D; Department of Haematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic, Czech Republic.; Machu M; University Hospital Brno and Faculty of Medicine, Masaryk University Brno, Brno, Czech Republic.; Tsakirakis N; Department of Biology, National and Kapodistrian University of Athens, Athens, Greece, Greece.; Bakouros P; Department of Biology, National and Kapodistrian University of Athens, Athens, Greece, Greece.; Tsitsilonis O; Department of Biology, National and Kapodistrian University of Athens, Athens, Greece, Greece.; Solia I; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece, Greece.; Moreno C; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC number CB16/12/00369, Pamplona, Spain, Spain.; Maia C; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC number CB16/12/00369, Pamplon, Pamplona, Spain.; Martin-Sanchez E; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC number CB16/12/00369, Pamplona, Spain, Spain.; Pérez JJ Sr; Hospital Universitario de Salamanca Hematología. Instituto de investigación biomédica de Salamanca (IBSAL), CIBER-ONC number CB16/12/00233, Salamanca, Spain, Spain.; Encinas C; Hospital General Universitario Gregorio Marañón, liSGM, Madrid, Spain, Spain.; Ríos-Tamayo R; Hospital Universitario Virgen de las Nieves, Granada, Spain.; Oriol A; Institut Català d'Oncologia and Institut Josep Carreras, Badalona, Barcelona, Spain, Spain.; Blanchard MJ; Hospital Universitario Ramon y Cajal, Madrid, Spain.; de Arriba F; Hospital Morales Meseguer, IMIB-Pascual Parrilla, Universidad de Murcia, Murcia, Spain, Spain.; González-García E; Hospital Universitairo Cabueñes, Gijón, Spain, Spain.; Lakhwani S; Hospital Universitario de Canarias, Universidad de la Laguna, Santa Cruz de Tenerife, Spain, Spain.; Sureda A; Institut Català d'Oncologia and Institut Josep Carreras, Badalona, Barcelona, Spain, Spain.; Cabañas V; Department of Hematology, IMIB-Virgen de la Arrixaca University Hospital. University of Murcia, Murcia, Spain, Spain.; Escalante F; Complejo Hospitalario de León, León, Spain, Spain.; Carrillo-Cruz E; Virgen del Rocío University Hospital, Sevilla, Spain.; Pérez-Montaña A; Hospital Universitario Son Espases, Palma, Spain, Spain.; Ocio EMM; University Hospital Marqués de Valdecilla (IDIVAL), University of Cantabria, Santander, Spain.; Bargay J; Hospital Universitario Son Llatzer, Institut d' investigacio Illes Balears (IdISBa), Palma de Mallorca, Spain, Spain.; Orfao A; Department of Medicine and Cytometry Service, Centro de Investigacion del Cancer (IBMCC, USAL-CSIC), University of Salamanca, CIBER-ONC CB16/12/00400, Salamanca, Spain, Spain, Spain.; Jelínek T; Department of Haematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic, Czech Republic.; Ghobrial IM; 3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; 4Harvard Medical School, Boston, MA; 5Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, United States.; Mutis T; 6Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands; 7Cancer Biology and Immunology, Cancer Center Amsterdam, Amsterdam, Netherlands, Netherlands.; Zweegman S; 6Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands; 7Cancer Biology and Immunology, Cancer Center Amsterdam, Amsterdam, Netherlands, Netherlands.; Terpos E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece, Greece.; Kastritis E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece, Greece.; Martínez-López J; Hospital Universitario 12 de Octubre, CIBER-ONC number CB16/12/00369, Madrid, Spain, Spain.; Lahuerta JJ; Hospital Universitario 12 de Octubre, CIBER-ONC number CB16/12/00369, Madrid, Spain, Spain.; Fernández de Larrea C; Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain, Spain.; Rosiñol L; Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain, Spain.; Bladé J; Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain, Spain.; Mateos MV; Hospital Universitario de Salamanca Hematología. Instituto de investigación biomédica de Salamanca (IBSAL), CIBER-ONC number CB16/12/00233, Salamanca, Spain, Spain.; San-Miguel JF; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC number CB16/12/00369, Spain.; Cedena MT; Hospital Universitario 12 de Octubre, Madrid, Spain.; Puig N; Hospital Universitario de Salamanca Hematología. Instituto de investigación biomédica de Salamanca (IBSAL), CIBER-ONC number CB16/12/00233, Salamanca, Spain, Spain.; Paiva B; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC number CB16/12/00369, Pamplona, Spain, Spain.
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Academic Journal
Rodríguez-Lobato LG; Amyloidosis and Multiple Myeloma Unit, Department of Hematology, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain. lgrodriguez@clinic.cat.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. lgrodriguez@clinic.cat.; de Daniel A; Amyloidosis and Multiple Myeloma Unit, Department of Hematology, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Pereira A; Amyloidosis and Multiple Myeloma Unit, Department of Hematology, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Fernández de Larrea C; Amyloidosis and Multiple Myeloma Unit, Department of Hematology, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Tovar N; Amyloidosis and Multiple Myeloma Unit, Department of Hematology, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Cibeira MT; Amyloidosis and Multiple Myeloma Unit, Department of Hematology, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Moreno DF; Amyloidosis and Multiple Myeloma Unit, Department of Hematology, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Mateos JM; Amyloidosis and Multiple Myeloma Unit, Department of Hematology, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Llobet N; Amyloidosis and Multiple Myeloma Unit, Department of Hematology, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.; Carcelero E; Department of Farmacology, Hospital Clínic de Barcelona, Barcelona, Spain.; Munárriz D; Amyloidosis and Multiple Myeloma Unit, Department of Hematology, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Bladé J; Amyloidosis and Multiple Myeloma Unit, Department of Hematology, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Rosiñol L; Amyloidosis and Multiple Myeloma Unit, Department of Hematology, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain. lrosinol@clinic.cat.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. lrosinol@clinic.cat.
Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Fernández-de-Larrea, N.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어